RICHARD KINCAID: Open Payments
NPI 1073742250 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 47 payments from 13 companies in 2025. Trend: 2023 $2,201 · 2024 $1,789 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $242 |
| Novo Nordisk Inc | 12 | $201 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Astellas Pharma US Inc | 3 | $67 |
| ABBVIE INC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| SANOFI-AVENTIS U.S. LLC | 2 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: TRELEGY ELLIPTA, Ozempic, Veozah, Wegovy, QULIPTA, AIRSUPRA, FARXIGA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
